Verona Pharma Plc ADR (VRNA) Stock Price, Quote & News

Company Profile

Verona Pharma plc, a biopharmaceutical company, focuses on development and commercialization of therapies for the treatment of respiratory diseases with unmet medical needs. The company offers Ohtuvayre, a dual inhibitor of the phosphodiesterase (PDE) 3 and PDE4 enzymes that combines bronchodilator and non-steroidal anti-inflammatory effects for the maintenance treatment of chronic obstructive pulmonary disease, as well as cystic fibrosis and asthma. Verona Pharma plc was incorporated in 2005 an...

Industry: Biotechnology

Sector: Healthcare

Phone: 44 20 3283 4200

Website: www.veronapharma.com

Address:

3 More London Riverside, London, United Kingdom

chickenboy Jun. 26 at 5:53 PM

$VRNA I didn't wake up today thinking I needed to buy more but I had a t-bill mature day and schwab pays almost nothing on sweeps so it felt like the thing to do. Volume reminiscent of April '24.

0 · Reply

Thorntonsprings Jun. 26 at 5:35 PM

$VRNA slingshot up ? Clear out the sellers. 2nd qtr almost over!

1 · Reply

techj2022 Jun. 26 at 3:34 PM

$VRNA look at the tiny volume on down days.

1 · Reply

barlaw Jun. 26 at 3:12 PM

$VRNA Feels like it could be a $3 or $4 day today, and if not today, then tomorrow.

1 · Reply

FE123 Jun. 26 at 2:58 PM

$TGTX $VRNA $SLNO $CYN Get that Green!!!

0 · Reply

badprecog Jun. 26 at 2:00 PM

$VRNA Its go to go green on approval-versary day?!!!

0 · Reply

YungBullHOLLA Jun. 26 at 12:24 PM

$VRNA happy 1 year approval-versary! Holla holla

4 · Reply

BullriderNkg Jun. 26 at 10:52 AM

$VRNA Short interest has actually declined a little. Q2 IMO, will lead to big purchases and confirmation to analysts thoughts that Ohtuvayre's trend to block buster status.

0 · Reply

RunnerSignals Jun. 26 at 3:42 AM

Short Squeeze Watch $RMBS $VEEV $VRNA $MASI $HSIC are catching attention with rising trends and shifting short interest. Could a squeeze be brewing? https://stocksrunner.com/news/2025-06-25-13-high-short-interest-stocks-primed-for-a-short-squeeze

1 · Reply

chickenboy Jun. 25 at 9:39 PM

$VRNA Let's see...we dropped a couple of bucks...hmmm, I guess it's time to cue up the ta guys with charts in hand to tell us we all idiots not to short the stock and its on its way to the $40's. Too f'ing hot here for me to care. Still

3 · Reply

Verona Pharma: A Blockbuster Franchise In The Making

Jun 4, 2025, 6:10 PM EDT - 22 days ago

Mizuho's Jared Holz details potential biotech, pharma acquisitions

INSM LEGN

May 21, 2025, 6:00 AM EDT - 5 weeks ago

Verona Pharma Announces June 2025 Investor Conference Participation

May 6, 2025, 6:00 AM EDT - 7 weeks ago

Verona Pharma to Present Seven Analyses of the Phase 3 ENHANCE Studies in COPD at ATS 2025

May 1, 2025, 8:51 AM EDT - 2 months ago

Silencing The Doubters: Verona Pharma Could Be Sitting On A Blockbuster

Apr 29, 2025, 3:45 PM EDT - 2 months ago

Verona Pharma plc (VRNA) Q1 2025 Earnings Call Transcript

Apr 29, 2025, 6:00 AM EDT - 2 months ago

Verona Pharma Reports First Quarter 2025 Financial Results and Provides Corporate Update

Apr 7, 2025, 10:47 AM EDT - 2 months ago

Verona Pharma's Bull Case Holds, But Lifecycle Extension Is Critical

Mar 28, 2025, 7:00 AM EDT - 3 months ago

Verona Pharma Announces Amended Strategic Financing with Oaktree and OMERS

Feb 27, 2025, 2:31 PM EST - 4 months ago

Verona Pharma plc (VRNA) Q4 2024 Earnings Call Transcript

Feb 27, 2025, 6:00 AM EST - 4 months ago

Verona Pharma Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Corporate Update

Feb 18, 2025, 6:00 AM EST - 4 months ago

Verona Pharma Announces March 2025 Investor Conference Participation

Feb 13, 2025, 6:00 AM EST - 4 months ago

Verona Pharma to Report Fourth Quarter and Full Year 2024 Financial Results and Provide Corporate Update

Jan 8, 2025, 1:45 PM EST - 6 months ago

Verona Pharma's Ohtuvayre Defies Expectations In Q4, But Stock Alpha May Now Be Limited

Jan 7, 2025, 6:00 AM EST - 6 months ago

Verona Pharma Reports Strong Ohtuvayre™ Launch and Provides Preliminary Fourth Quarter and Full Year 2024 Financial Highlights

Nov 19, 2024, 2:00 AM EST - 7 months ago

Verona Pharma Announces December 2024 Investor Conference Participation

Nov 9, 2024, 8:23 AM EST - 8 months ago

Caligan picks up a stake in Verona Pharma, seeing an opportunity to generate more value

Nov 5, 2024, 2:00 AM EST - 8 months ago

Verona Pharma to Present at Jefferies London Healthcare Conference

Nov 4, 2024, 11:47 AM EST - 8 months ago

Verona Pharma plc (VRNA) Q3 2024 Earnings Call Transcript

Nov 4, 2024, 2:00 AM EST - 8 months ago

Verona Pharma Reports Third Quarter 2024 Financial Results and Provides Corporate Update

Oct 21, 2024, 2:00 AM EDT - 8 months ago

Verona Pharma to Report Third Quarter 2024 Financial Results and Provide Corporate Update

Oct 8, 2024, 5:00 AM EDT - 9 months ago

Virometix appoints Christina Ackermann as Chair and Tim Ramdeen as member of the Board

ENTO OCS ONCO

Sep 30, 2024, 2:00 AM EDT - 9 months ago

Verona Pharma to Present Six Analyses of the Phase 3 ENHANCE Studies in COPD at CHEST 2024

Sep 14, 2024, 4:20 AM EDT - 10 months ago

Verona Pharma's Ohtuvayre Set To Unlock Significant Value In COPD Care

Sep 5, 2024, 2:00 AM EDT - 10 months ago

Verona Pharma to Present Additional Analyses of Phase 3 ENHANCE Studies in COPD at ERS International Congress 2024

Aug 14, 2024, 8:35 AM EDT - 11 months ago

Top 3 Health Care Stocks That May Crash In August

CAH CPRX

Aug 8, 2024, 1:15 PM EDT - 11 months ago

Verona Pharma plc (VRNA) Q2 2024 Earnings Call Transcript

Aug 8, 2024, 2:00 AM EDT - 11 months ago

Verona Pharma Reports Second Quarter 2024 Financial Results and Provides Corporate Update

Jul 30, 2024, 10:13 AM EDT - 11 months ago

Top 3 Health Care Stocks You May Want To Dump This Quarter

CPRX VRDN

Jul 30, 2024, 2:00 AM EDT - 11 months ago

Verona Pharma to Present at 44th Annual Canaccord Growth Conference

Jul 25, 2024, 2:00 AM EDT - 1 year ago

Verona Pharma to Report Second Quarter 2024 Financial Results and Provide Corporate Update

Jun 30, 2024, 9:00 AM EDT - 1 year ago

Verona Pharma Is Launching Ohtuvayre, Although There Will Be Competition

Jun 27, 2024, 9:49 AM EDT - 1 year ago

First Inhaled COPD Therapy In Over 2 Decades - FDA Approves Verona Pharma's First Commercial Product

Jun 27, 2024, 9:03 AM EDT - 1 year ago

Verona Pharma's inhaled COPD therapy to be priced at $2,950 per month

Jun 26, 2024, 5:13 PM EDT - 1 year ago

US FDA approves Verona Pharma's therapy for 'smoker's lungs'

Jun 26, 2024, 4:57 PM EDT - 1 year ago

Verona Pharma Announces US FDA Approval of Ohtuvayre™ (ensifentrine)

Jun 24, 2024, 4:51 AM EDT - 1 year ago

5 Biotech Stocks With Key Catalysts This Week: Merck, Intellia, Verona, And More

MRK NTLA ARWR XFOR

Jun 20, 2024, 12:45 PM EDT - 1 year ago

Verona Pharma: Next Week's PDUFA Date Ought To Provide An Upside Catalyst

May 9, 2024, 12:31 PM EDT - 1 year ago

Verona Pharma plc (VRNA) Q1 2024 Earnings Call Transcript

May 9, 2024, 7:15 AM EDT - 1 year ago

Verona Pharma Reports First Quarter 2024 Financial Results and Provides Corporate Update

May 9, 2024, 7:00 AM EDT - 1 year ago

Verona Pharma Announces $650 Million Strategic Financing with Oaktree and OMERS

May 2, 2024, 2:00 AM EDT - 1 year ago

Verona Pharma to Present Additional Analyses of Positive Phase 3 ENHANCE Studies in COPD at ATS 2024

Apr 25, 2024, 2:00 AM EDT - 1 year ago

Verona Pharma to Report First Quarter 2024 Financial Results and Provide Corporate Update

Mar 4, 2024, 2:00 AM EST - 1 year ago

Andrew Fisher Joins Verona Pharma as General Counsel

Feb 29, 2024, 12:36 PM EST - 1 year ago

Verona Pharma plc (VRNA) Q4 2023 Earnings Call Transcript

Feb 29, 2024, 2:00 AM EST - 1 year ago

Verona Pharma Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update

Feb 15, 2024, 2:00 AM EST - 1 year ago

Verona Pharma to Report Fourth Quarter and Full Year 2023 Financial Results and Provide Corporate Update

Feb 1, 2024, 2:00 AM EST - 1 year ago

Michael Austwick Joins Verona Pharma as Non-Executive Director

Jan 3, 2024, 2:00 AM EST - 1 year ago

Verona Pharma to Present at 42nd Annual J.P. Morgan Healthcare Conference

Jan 2, 2024, 2:00 AM EST - 1 year ago

Verona Pharma enters into Debt Facility of up to $400 Million with Oxford Finance and Hercules Capital

chickenboy Jun. 26 at 5:53 PM

$VRNA I didn't wake up today thinking I needed to buy more but I had a t-bill mature day and schwab pays almost nothing on sweeps so it felt like the thing to do. Volume reminiscent of April '24.

0 · Reply

Thorntonsprings Jun. 26 at 5:35 PM

$VRNA slingshot up ? Clear out the sellers. 2nd qtr almost over!

1 · Reply

techj2022 Jun. 26 at 3:34 PM

$VRNA look at the tiny volume on down days.

1 · Reply

barlaw Jun. 26 at 3:12 PM

$VRNA Feels like it could be a $3 or $4 day today, and if not today, then tomorrow.

1 · Reply

FE123 Jun. 26 at 2:58 PM

$TGTX $VRNA $SLNO $CYN Get that Green!!!

0 · Reply

badprecog Jun. 26 at 2:00 PM

$VRNA Its go to go green on approval-versary day?!!!

0 · Reply

YungBullHOLLA Jun. 26 at 12:24 PM

$VRNA happy 1 year approval-versary! Holla holla

4 · Reply

BullriderNkg Jun. 26 at 10:52 AM

$VRNA Short interest has actually declined a little. Q2 IMO, will lead to big purchases and confirmation to analysts thoughts that Ohtuvayre's trend to block buster status.

0 · Reply

RunnerSignals Jun. 26 at 3:42 AM

1 · Reply

chickenboy Jun. 25 at 9:39 PM

3 · Reply

Thorntonsprings Jun. 25 at 3:51 PM

$VRNA Going to hit the Century mark. Almost done with 2nd qtr.

0 · Reply

badprecog Jun. 25 at 3:34 PM

$VRNA Emotionally I am no longer equipped for Verona to have a down day. its been so long. But then again it will probably go positive this afternoon.

5 · Reply

Datum Jun. 25 at 2:59 PM

$VRNA imagine looking back at this chart someday after a few stock splits and this run looks like $0.08 to $6.3.

0 · Reply

Trainguy1 Jun. 25 at 12:05 PM

$VRNA We just went over $100 pre-market.

2 · Reply

Kingjake26 Jun. 25 at 10:32 AM

$VRNA Very excited. We called triple digit over a year ago. Very emotional. Let’s get it today. :)

3 · Reply

Stockman123345 Jun. 25 at 4:48 AM

$VRNA i personally think this is $150-180 minimum by EOY if launch is going as successful as its been past two Qs

2 · Reply

Dark_Horse_Investments Jun. 24 at 10:55 PM

Is $INSM market capitalization realistic for $VRNA ? INSM $20 B : VRNA $8.3 B Is this a fair comparison? Consider, INSM raised ~$750M has a marginally bigger product portfolio. Comparable revenue estimates from ~$350M to ~$450M for both cos but INSM 2026 estimates over $1B (vrna under a bill as analysts go). Share any substantive thoughts. THX in advance

2 · Reply

barlaw Jun. 24 at 8:43 PM

$VRNA Nice touché of $99 today. She’s sure moving fast enough to keep me giddy! Not long ago people were talking rapturously about “$100 by EOY!” Now I think we can expect $125/$135!

0 · Reply

Crush_it Jun. 24 at 5:43 PM

$VRNA They have a blockbuster drug $100 is a given and $135 is next.

0 · Reply

badprecog Jun. 24 at 5:14 PM

$VRNA Be interesting to see how long it takes to break $100. If that is a resistance point of if it just climbs through it like it did for every other number.

1 · Reply

Thorntonsprings Jun. 24 at 5:07 PM

$VRNA fat long and happy with this company. I won’t be selling at $100 but I’ll damn sure be celebrating!

1 · Reply

BDE_Worldwide Jun. 24 at 5:04 PM

$VRNA sorry if this was already posted..

3 · Reply

Market Cap	7.88B
Revenue (ttm)	42.28M
Net Income (ttm)	-173.42M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	526.63
Profit Margin	-410.17%
Debt to Equity Ratio	1.07

Volume	788,300
Avg Vol	1,359,452
Day's Range	N/A - N/A
Shares Out	81.08M
Stochastic %K	60%
Beta	0.21
Analysts	Strong Sell
Price Target	$114.00